Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
Analytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisOpen Platform
Professional Services
Customer Stories
Newsroom
Blog
Global Innovation Report
Glossary
Webinars & Training
Frontier
User Community
Trust and Security
PatentBench
LLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report How AI is transforming systematic literature review for technology platform development — faster screening, smarter synthesis, and patent-aware R&D workflows.
Article | Report Explore the 2026 copper alloy materials landscape for EV motor windings and power connectors. Key IP spaces, technology gaps, and dominant material strategies.
Article | Report A deep analysis of edge AI inference accelerator technology in 2026: dedicated silicon, FPGA, PIM architectures, NAS, and distributed inference across 80+ patent and literature records.
Article | Report Fenebrutinib vs. tolebrutinib: how CNS-penetrant BTK inhibitors target smoldering lesions and microglia in progressive MS. Phase III data signals analysed.
Article | Report The 2026 nickel superalloy landscape for gas turbine blades and additive manufacturing: key data sources, research gaps, and how to retrieve patent intelligence.
Article | Report TGA vs DSC for polymer degradation: understand which thermal analysis technique reveals mass loss, heat flow, or transition data—and when to use both together.
Article | Report Monopile foundations dominate 80% of offshore wind capacity. Explore the 2026 technology landscape: PISA models, TP-less designs, XXL monopiles, and key patents.
Article | Report Explore the key technical barriers to cost-competitive direct lithium extraction (DLE) from geothermal brine, from ion selectivity to scaling challenges.
Article | Report Dostarlimab (Jemperli) PD-1 inhibitor Phase III expansion in dMMR endometrial and colorectal cancer: GSK's biomarker-driven immunotherapy strategy explained.
Article | Report Titanium alloy patent landscape 2026: aerospace lightweighting and medical implants. Key alloy systems, IPC codes, assignees, and how to build a rigorous IP dataset.
Article | Report Explore the 2026 thermoelectric materials landscape: Bi₂Te₃, PbTe, and Half-Heusler alloys for waste heat recovery. Patent trends, ZT advances, and IP intelligence.
Article | Report Belantamab mafodotin (Blenrep) Phase III DREAMM readouts, reformulated combinations, and the GSK vs. daratumumab BCMA race in multiple myeloma.
Article | Report A 2026 technology landscape of continuous wearable blood pressure monitors: PTT, PPG, edge AI, ISO compliance, and key patent assignees mapped from 2012–2025 filings.
Article | Report How do model-based and measurement-based EMF simulation methods differ for vehicle antenna placement? A technical guide for automotive RF and EMC engineers.
Article | Report Depemokimab (Exdensur), GSK's ultra-long-acting anti-IL-5 biologic, offers twice-yearly dosing for severe asthma and CRSwNP. Explore the competitive IL-5 inhibitor landscape.